Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 55 citing Ortegon: Cost-effectiveness of prevention and treatment of the diabetic foot. (0.10 sec) 

Preventing foot ulcers in patients with diabetes


N Singh, DG Armstrong, BA Lipsky - Jama, 2005 - Am Med Assoc
Context Among persons diagnosed as having diabetes mellitus, the prevalence of
foot ulcers is 4% to 10%, the annual population-based incidence is 1.0% to 4.1%,
and the lifetime incidence may be as high as 25%. These ulcers frequently ...
Cited by 333 - Related articles - All 5 versions

The global burden of diabetic foot disease

- ptolemy.ca [PDF] 
AJM Boulton, L Vileikyte, G Ragnarson- … - The Lancet, 2005 - Elsevier
Diabetic foot problems are common throughout the world, resulting in major
economic consequences for the patients, their families, and society. Foot ulcers
are more likely to be of neuropathic origin, and therefore eminently ...
Cited by 206 - Related articles - All 29 versions

[PDF] Diabetic foot disorders


RG Frykberg, MPH DPM, DG Armstrong, J DPM … - Data Trace - apwca.com
Page 1. DIABETIC FOOT DISORDERS A Clinical Practice Guideline Robert G.
Frykberg, DPM, MPH, David G. Armstrong, DPM, John Giurini ...
Cited by 165 - Related articles - View as HTML - BL Direct - All 18 versions

Treatment for diabetic foot ulcers

- ptolemy.ca [PDF] 
PR Cavanagh, BA Lipsky, AW Bradbury, G … - The Lancet, 2005 - Elsevier
People with diabetes develop foot ulcers because of neuropathy (sensory, motor,
and autonomic deficits), ischaemia, or both. The initiating injury may be from
acute mechanical or thermal trauma or from repetitively or continuously ...
Cited by 93 - Related articles - All 21 versions

Diabetic foot disorders: a clinical practice guideline (2006 revision)


RG Frykberg, T Zgonis, DG Armstrong, VR … - The journal of Foot and Ankle Surgery, 2006 - Elsevier
Foot ulcerations, infections, Charcot neuroarthropathy, and peripheral arterial
disease frequently result in gangrene and lower limb amputation. Consequently,
foot disorders are leading causes of hospitalization for persons with ...
Cited by 55 - Related articles - All 2 versions

Changing the natural history of diabetic neuropathy: incidence of ulcer/amputation in the …

- prsjournal.net
O Aszmann, PL Tassler, AL Dellon - Annals of plastic surgery, 2004 - journals.lww.com
From the *Department of Plastic Surgery, University of Vienna, Austria; the
†Vermont Department of Health, Burlington, Vermont; and the ‡Division of
Plastic Surgery and Department of Neurosurgery, Johns Hopkins University, ...
Cited by 44 - Related articles - All 8 versions

Epidemiology and health care costs of diabetic foot problems


GE Reiber, LV McFarland - The Diabetic Foot, 2006 - Springer
The global prevalence of diabetes is predicted to double by the year 2030 from
2.8% to 4.4% (1). Of individuals with diabetes, a substantial number will
develop lower extremity disease including peripheral neuropathy, foot ...
Cited by 21 - Related articles - All 3 versions

Barriers to the delivery of diabetic foot care


WH van Houtum - The Lancet, 2005 - Elsevier
The foot in diabetes can be affected by ulceration, infection, and gangrene, and
is a source of major morbidity and mortality, yet it has been neglected by
health-care services. In recent years, however, the level of interest and ...
Cited by 15 - Related articles - All 11 versions

Patient-centred and professional-directed implementation strategies for diabetes guidelines: …


RF Dijkstra, LW Niessen, JC Braspenning, E … - Diabetic Medicine, 2006 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 11 - Related articles - BL Direct - All 6 versions

An off-the-shelf instant contact casting device for the management of diabetic foot ulcers: a …

- diabetesjournals.org
A Piaggesi, S Macchiarini, L Rizzo, F Palumbo, … - Diabetes care, 2007 - Am Diabetes Assoc
RESULTS—No difference between groups A and B was observed in healing rates at
12 weeks (95 vs. 85%), healing time (6.5 ± 4.4 vs. 6.7 ± 3.4 weeks), and
number of adverse events (six versus four). Treatment was significantly ...
Cited by 11 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google